Associated Papers
IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation.
Malvestiti F et al.
International Journal of Molecular Sciences, 2026
The Association of PLA2G7 Gene Polymorphisms with Serum Lp-PLA2 Activity and Lipid Profile in Han Chinese Patients with Coronary Heart Disease.
Wang Y et al.
Pharmacogenomics and Personalized Medicine, 2024
Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease.
Ma S et al.
Disease Markers, 2022
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge.
Brancaccio M et al.
Diagnostics (basel, Switzerland), 2021
Human Secretary Phospholipase A2 Mutations and Their Clinical Implications.
Khan MI et al.
Journal of Inflammation Research, 2020
Evolutionary history of human colitis-associated colorectal cancer.
Baker AM et al.
Gut, 2019
Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population.
Chi Y et al.
Journal of Thrombosis and Thrombolysis, 2018
Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.
Yeo A et al.
Plos One, 2017
Associations between four types of single-nucleotide polymorphisms in PLA2G7 gene and clinical atherosclerosis: a meta-analysis.
Santoso A et al.
American Journal of Cardiovascular Disease, 2017
A previously unreported impact of a PLA2G7 gene polymorphism on the plasma levels of lipoprotein-associated phospholipase A2 activity and mass.
Qi Y et al.
Scientific Reports, 2016
Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy.
Peng LL et al.
Acta Pharmacologica Sinica, 2016
Association between Ala379Val polymorphism of lipoprotein-associated phospholipase A2 and migraine without aura in Iranian population.
Haghdoost F et al.
Iranian Journal of Neurology, 2016
Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population.
Hong M et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society, 2015
Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trial.
Tremblay BL et al.
Lipids in Health and Disease, 2015
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X et al.
Nucleic Acids Research, 2014
Associations of platelet-activating factor acetylhydrolase (PAF-AH) gene polymorphisms with circulating PAF-AH levels and risk of coronary heart disease or blood stasis syndrome in the Chinese Han population.
Zheng GH et al.
Molecular Biology Reports, 2014
The prevalence of platelet activating factor acetylhydrolase single nucleotide polymorphisms in relationship to necrotizing enterocolitis in Northwest Louisiana infants.
Sankararaman S et al.
Springerplus, 2013
Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies.
Grallert H et al.
European Heart Journal, 2012
Recent progress in phospholipase A₂ research: from cells to animals to humans.
Murakami M et al.
Progress in Lipid Research, 2011
PLA2G7 gene polymorphisms and coronary heart disease risk: a meta-analysis.
Wang Q et al.
Thrombosis Research, 2010
Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study.
Suchindran S et al.
Plos Genetics, 2010
Genetic deficiency of plasma lipoprotein-associated phospholipase A2 (PLA2G7 V297F null mutation) and risk of Alzheimer's disease in Japan.
Koshy B et al.
Journal of Alzheimer's Disease : Jad, 2010
Association of PLA2G7 polymorphisms with carotid atherosclerosis in hypertensive Japanese.
Miwa Y et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2009
Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene.
Stafforini DM
Pharmaceuticals (basel, Switzerland), 2009
Inter-individual variability of plasma PAF-acetylhydrolase activity in ARDS patients and PAFAH genotype.
Li S et al.
Journal of Clinical Pharmacy and Therapeutics, 2009
Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study.
Hou L et al.
Human Genetics, 2009
Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study).
Hoffmann MM et al.
Journal of Thrombosis and Haemostasis : Jth, 2009
Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis.
Samanta U et al.
The Journal of Biological Chemistry, 2008
Identification of candidate genes for human retinal degeneration loci using differentially expressed genes from mouse photoreceptor dystrophy models.
Demos C et al.
Molecular Vision, 2008
Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein.
Gardner AA et al.
The Journal of Biological Chemistry, 2008
Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets.
Sutton BS et al.
Human Molecular Genetics, 2008
Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians.
Campo S et al.
Aging Clinical and Experimental Research, 2008
Exploration of associations between phospholipase A2 gene family polymorphisms and AIDS progression using the SNPlex method.
Limou S et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2008
Two new highly polymorphic markers in the 3' UTR region of the PLA2G7 gene.
Gomez Lira M et al.
International Journal of Immunogenetics, 2007
Association of sixty-one non-synonymous polymorphisms in forty-one hypertension candidate genes with blood pressure variation and hypertension.
Kokubo Y et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2006
Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction.
Liu PY et al.
Journal of Thrombosis and Haemostasis : Jth, 2006
Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
Ninio E et al.
Human Molecular Genetics, 2004
Platelet-activating factor acetylhydrolase gene polymorphism and its activity in Japanese patients with multiple sclerosis.
Osoegawa M et al.
Journal of Neuroimmunology, 2004
The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
Kakafika AI et al.
Journal of Lipid Research, 2003
Interdependent effect of angiotensin-converting enzyme and platelet-activating factor acetylhydrolase gene polymorphisms on the progression of immunoglobulin A nephropathy.
Yoon HJ et al.
Clinical Genetics, 2002
Lack of evidence for associations between plasma platelet-activating factor acetylhydrolase deficiency and schizophrenia.
Ohtsuki T et al.
Psychiatry Research, 2002
The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma.
Kruse S et al.
American Journal of Human Genetics, 2000
Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma.
Stafforini DM et al.
The Journal of Clinical Investigation, 1999
Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
Ryu SK et al.
Journal of Clinical Lipidology, 0